Cargando…
Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer
Recent studies suggested that calreticulin (CRT) has an important role in the progression of various types of cancer. Our previous study suggested that CRT was upregulated and acted as an oncogene in hepatocellular carcinoma. However, the role of CRT in gallbladder cancer (GBC) remains unclear. The...
Autores principales: | Ye, Jianwen, Qi, Lei, Du, Zhicheng, Yu, Long, Chen, Kunlun, Li, Renfeng, Feng, Ruo, Zhai, Wenlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950265/ https://www.ncbi.nlm.nih.gov/pubmed/33591948 http://dx.doi.org/10.18632/aging.202488 |
Ejemplares similares
-
Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells
por: Feng, Ruo, et al.
Publicado: (2015) -
Metformin suppresses hypoxia-induced migration via the HIF-1α/VEGF pathway in gallbladder cancer in vitro and in vivo
por: Ye, Jianwen, et al.
Publicado: (2019) -
Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
por: Ye, Jianwen, et al.
Publicado: (2021) -
Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021) -
Interleukin 17A promotes gallbladder cancer invasiveness via ERK/NF-κB signal pathway mediated epithelial-to-mesenchymal transition
por: Chen, Kunlun, et al.
Publicado: (2020)